Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae

This publication has 34 references indexed in Scilit:

• Pharmacodynamics of the New Fluoroquinolone Gatifloxacin in Murine Thigh and Lung Infection Models
  Antimicrobial Agents and Chemotherapy, 2002
• Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
  New England Journal of Medicine, 2002
• Guidelines for the Management of Adults with Community-acquired Pneumonia
  American Journal of Respiratory and Critical Care Medicine, 2001
• Pharmacokinetic and pharmacodynamic properties of antimicrobials in the therapy of respiratory tract infections
  Current Opinion in Infectious Diseases, 2001
• The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae
  Diagnostic Microbiology and Infectious Disease, 2000
• Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
  Clinical Infectious Diseases, 2000
• Antimicrobial Resistance with Streptococcus pneumoniae in the United States, 1997–98
  Emerging Infectious Diseases, 1999
• A review of the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new ‘respiratory quinolones’
  Journal of Antimicrobial Chemotherapy, 1999
• State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
  Clinical Infectious Diseases, 1998
• Community-Acquired Pneumonia
  New England Journal of Medicine, 1995